Elevated Gal-3 concentrations are known to be correlated with various inflammatory and fibrotic conditions, including idiopathic pulmonary fibrosis, cardiovascular disease, autoimmune diseases, cancer and osteoarthritis, but no data is yet available on lung transplant patients [35, 36]. Here, LGALS3 is linked to cardiovascular disorder.